Arena Pharmaceuticals and United Therapeutics $1.2 Billion Global License Agreement

Wilson Sonsini Goodrich & Rosati is representing United Therapeutics in the transaction. Arena Pharmaceuticals, Inc. (Nasdaq: ARNA) and United Therapeutics Corporation (Nasdaq: UTHR) have entered into...

Standard 1 Year Membership Required

You must be a Standard 1 Year member to access this content.

Join Now

Already a member? Log in here